Offer - Urjas Oil for just ₹ 1 X
Glimixia VM1 Tablet ER is a prescription medicine that is available as a Tablet. It is typically used for the treatment of Diabetes.
The correct dosage of Glimixia VM1 Tablet ER depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Glimixia VM1 Tablet ER can also lead to other problems, which have been listed below. Normally, these side effects of Glimixia VM1 Tablet ER are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Glimixia VM1 Tablet ER is Moderate for pregnant women and Unknown for women who are breastfeeding. It is important to know if Glimixia VM1 Tablet ER has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Glimixia VM1 Tablet ER related warnings section.
Glimixia VM1 Tablet ER can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Glimixia VM1 Tablet ER in conditions like Heart Disease, Liver Disease, Kidney Disease. Some other conditions that can be affected by Glimixia VM1 Tablet ER are listed in the contraindications section below.
Drug reaction of Glimixia VM1 Tablet ER with other medicines has been reported. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Glimixia VM1 Tablet ER is safe while driving, and is is addictive in nature.
Glimixia VM1 Tablet ER is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glimixia VM1 Tablet ER safe for pregnant women?
Glimixia may have some side effects during pregnancy. Pregnant women should discontinue the use of Glimixia, and talk to their doctor, if they notice any discomfort.
Is the use of Glimixia VM1 Tablet ER safe during breastfeeding?
There is no research available on the side effects of Glimixia in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Glimixia VM1 Tablet ER on the Kidneys?
Glimixia may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Glimixia VM1 Tablet ER on the Liver?
There may be an adverse effect on the liver after taking Glimixia. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Glimixia VM1 Tablet ER on the Heart?
Glimixia has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Glimixia VM1 Tablet ER unless your doctor advises you to do so -
Is this Glimixia VM1 Tablet ER habit forming or addictive?
Glimixia VM1 Tablet ER is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Glimixia VM1 Tablet ER does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but consume Glimixia VM1 Tablet ER only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Glimixia VM1 Tablet ER for mental disorders.
Interaction between Food and Glimixia VM1 Tablet ER
There is no information on the effects of taking Glimixia VM1 Tablet ER with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Glimixia VM1 Tablet ER
Consumption of alcohol and Glimixia VM1 Tablet ER together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158